Original Research
Accepted on 31 Oct 2025
Toripalimab plus gemcitabine and cisplatin induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma (LANPC): A retrospective study
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
Type at least 3 characters
1,528 articles
Original Research
Accepted on 31 Oct 2025
Redox phenotype confers T cell-exclusion microenvironment and resistance to immunotherapy by suppressing STING/MDA5 expression and interferon signaling in lung cancers harboring KEAP1/STK11 mutations
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
Systematic Review
Accepted on 31 Oct 2025
First-Line Immunochemotherapy for Advanced NSCLC in Asian Patients: A Meta-Analysis of Phase 3 RCTs
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
Original Research
Accepted on 31 Oct 2025
Frailty Trajectories and Their Determinants in Cancer Patients Undergoing Immunotherapy: A Prospective Longitudinal Study
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
Case Report
Published on 31 Oct 2025
Case Report: IL-6 suppression: a potential strategy for mitigating severe immune-related adverse events in nivolumab and ipilimumab therapy for malignant pleural mesothelioma
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1671503
- 257 views
Mini Review
Published on 31 Oct 2025
Decoding the immune microenvironment in osteosarcoma: new insights into checkpoints, vaccines, and CAR-T cells
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1702219
- 232 views
Original Research
Published on 30 Oct 2025
Dual oncogenic role of RNF220 in AML: linking metabolic rewiring to cell proliferation and immune evasion
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1670895
- 178 views
Original Research
Accepted on 29 Oct 2025
First-line Immune Checkpoint Inhibitors Combined with Chemotherapy in Advanced Large-cell Neuroendocrine Carcinoma of the Lung: A Real-world Retrospective Study
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
- 132 views
Systematic Review
Published on 29 Oct 2025
Navigating the risks: a systematic review of immune checkpoint inhibitor therapy before liver transplant for hepatocellular carcinoma and its impact on allograft rejection and survival outcomes
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1689820
- 418 views
Review
Published on 29 Oct 2025
Antibody–drug conjugate: a newly developed biological missile for tumor treatment
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1688057
- 876 views
Original Research
Accepted on 28 Oct 2025
Association Between Immune-Related Adverse Events and Recurrence Dynamics Under Adjuvant Anti– PD-1 Therapy in Resected Melanoma
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
- 125 views
Original Research
Accepted on 28 Oct 2025
Phytochemical and Nanoparticle-Based Therapeutic Potential of Sphaeranthus indicus Against Hepatocellular Carcinoma via Cryptomeridiol Targeting
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
Original Research
Accepted on 28 Oct 2025
Early C-Reactive Protein Reduction Predicts Survival in Real-World Extensive-Stage Small Cell Lung Cancer Treated with First-Line Adebrelimab-Based Immunotherapy
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
Case Report
Accepted on 28 Oct 2025
Accelerated Parathyroid Adenoma Progression and Hypercalcemia-Driven Neurotoxicity Following Pembrolizumab-Based Neoadjuvant Therapy in Triple-Negative Breast Canc er: A Case of Multisystem Immune-Related Adverse Events
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
- 106 views
Case Report
Published on 28 Oct 2025
Immune-related osteitis mimicking femoral head osteonecrosis during dual checkpoint blockade: a case report
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1621774
- 380 views
Mini Review
Published on 28 Oct 2025
Integrated molecular and microenvironmental drivers of drug resistance in gastrointestinal cancers: mechanisms, immunotherapy challenges, and precision strategies
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1675745
- 340 views